Expertise in
1
conditions

Sung-ching U. Pan

Number 7, Chung Shan South Road, 
TPQ, TW 
Expertise in
1
conditions
Number 7, Chung Shan South Road, 
TPQ, TW 

Overview

Sung-ching Pan practices practicing medicine in Taiwan.

Pan is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Hepatitis A, Miller-Fisher Syndrome, Severe Acute Respiratory Syndrome (SARS), and Whipple Disease.

They are actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 2 clinical trials.

Locations

Number 7, Chung Shan South Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II, Prospective, Randomized, Observer-blinded, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of Heterologous Booster Dose With AZD1222, mRNA-1273, or MVC-COV1901 COVID-19 Vaccine in Adults
A Phase II, Prospective, Randomized, Observer-blinded, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of Heterologous Booster Dose With AZD1222, mRNA-1273, or MVC-COV1901 COVID-19 Vaccine in Adults
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Biological
Study Phase: Phase 2
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Biological
Study Drug: AdimrSC-2f Vaccine
Study Phase: Phase 1
View 1 Less Clinical Trial

64 Total Publications

Trends of bacterial sexually transmitted infections with doxycycline post-exposure prophylaxis among people using pre-exposure prophylaxis for HIV.
Trends of bacterial sexually transmitted infections with doxycycline post-exposure prophylaxis among people using pre-exposure prophylaxis for HIV.
Journal: Sexually transmitted infections
Published: January 28, 2026

Frequently Asked Questions about Sung-ching U. Pan

Is Sung-ching U. Pan a top-rated expert for Hepatitis A?

MediFind is an objective health platform that identifies experts based on real-world data. Sung-ching U. Pan is classified as an Advanced expert for Hepatitis A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sung-ching U. Pan participate in research or clinical trials?

Yes. Sung-ching U. Pan has published 64 articles and abstracts on conditions like Hepatitis A. You can view a list of Sung-ching U. Pan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pan's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile